Skip to main content
. 2013 Feb 13;8(2):e56169. doi: 10.1371/journal.pone.0056169

Figure 5. MAP17 and SGLT1 levels and the combination are good independent markers for survival.

Figure 5

A) A Kaplan-Meier curve is shown indicating that MAP17 could be a good prognostic marker for survival in cervical tumor patients treated with cisplatin and radiotherapy. B) The impact function indicates the accumulated impact of having high MAP17 levels in the survival of cervical tumor patients treated with cisplatin and radiotherapy. C) A Kaplan-Meier curve is shown indicating that SGLT1 levels could be a good prognostic marker for survival in cervical tumor patients treated with cisplatin and radiotherapy. D) A Kaplan-Meier curve is shown indicating that high levels of MAP17 and SGLT1 levels are good prognostic markers for survival in cervical tumor patients treated with cisplatin and radiotherapy.